Literature DB >> 6381552

Value of serum C-reactive protein measurement in the management of bone marrow transplant recipients. Part II: Late post-transplant period.

S A Walker, P G Riches, T R Rogers, S White, J R Hobbs.   

Abstract

Seventeen bone marrow recipients transplanted for acute leukaemia (8), chronic leukaemia (1), severe aplastic anaemia (3), and various inborn errors of metabolism (5) had 22 episodes of documented infection in the late (greater than 3 months) post-transplant period. Serum C-reactive protein concentrations were considerably increased in patients with bacterial infections, but not in those with viral or fungal infections. Serum C-reactive protein values were normal in 20 patients transplanted for acute leukaemia (12), chronic leukaemia (1), severe aplastic anaemia (2), and various inborn errors of metabolism (5) who had active chronic graft versus host disease but no evidence of infection. These findings indicate that serum C-reactive protein concentrations are useful in the diagnosis and monitoring of bacterial infections even in the presence of chronic graft versus host disease.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6381552      PMCID: PMC498919          DOI: 10.1136/jcp.37.9.1022

Source DB:  PubMed          Journal:  J Clin Pathol        ISSN: 0021-9746            Impact factor:   3.411


  10 in total

1.  Analysis of late infections in 89 long-term survivors of bone marrow transplantation.

Authors:  K Atkinson; R Storb; R L Prentice; P L Weiden; R P Witherspoon; K Sullivan; D Noel; E D Thomas
Journal:  Blood       Date:  1979-04       Impact factor: 22.113

2.  The regulation of Ig synthesis after marrow transplantation. IV. T4 and T8 subset function in patients with chronic graft-vs-host disease.

Authors:  L G Lum; N Orcutt-Thordarson; M C Seigneuret; R Storb
Journal:  J Immunol       Date:  1982-07       Impact factor: 5.422

3.  Value of serum C-reactive protein measurement in the management of bone marrow transplant recipients. Part I: Early transplant period.

Authors:  S A Walker; T R Rogers; P G Riches; S White; J R Hobbs
Journal:  J Clin Pathol       Date:  1984-09       Impact factor: 3.411

4.  Solid phase radioimmunoassays for human C-reactive protein.

Authors:  B Shine; F C de Beer; M B Pepys
Journal:  Clin Chim Acta       Date:  1981-11-25       Impact factor: 3.786

5.  Chronic graft-versus-host disease in 52 patients: adverse natural course and successful treatment with combination immunosuppression.

Authors:  K M Sullivan; H M Shulman; R Storb; P L Weiden; R P Witherspoon; G B McDonald; M M Schubert; K Atkinson; E D Thomas
Journal:  Blood       Date:  1981-02       Impact factor: 22.113

6.  Pneumococcal infections after human bone-marrow transplantation.

Authors:  D J Winston; G Schiffman; D C Wang; S A Feig; C H Lin; E L Marso; W G Ho; L S Young; R P Gale
Journal:  Ann Intern Med       Date:  1979-12       Impact factor: 25.391

Review 7.  The pathophysiology and treatment of graft-versus-host disease.

Authors:  K M Sullivan; R Parkman
Journal:  Clin Haematol       Date:  1983-10

8.  Analysis of late infections after human bone marrow transplantation: role of genotypic nonidentity between marrow donor and recipient and of nonspecific suppressor cells in patients with chronic graft-versus-host disease.

Authors:  K Atkinson; V Farewell; R Storb; M S Tsoi; K M Sullivan; R P Witherspoon; A Fefer; R Clift; B Goodell; E D Thomas
Journal:  Blood       Date:  1982-09       Impact factor: 22.113

9.  Recovery of antibody production in human allogeneic marrow graft recipients: influence of time posttransplantation, the presence or absence of chronic graft-versus-host disease, and antithymocyte globulin treatment.

Authors:  R P Witherspoon; R Storb; H D Ochs; N Fluornoy; K J Kopecky; K M Sullivan; J H Deeg; R Sosa; D R Noel; K Atkinson; E D Thomas
Journal:  Blood       Date:  1981-08       Impact factor: 22.113

10.  In vitro regulation of immunoglobulin synthesis after marrow transplantation. I. T-cell and B-cell deficiencies in patients with and without chronic graft-versus-host disease.

Authors:  L G Lum; M C Seigneuret; R F Storb; R P Witherspoon; E D Thomas
Journal:  Blood       Date:  1981-09       Impact factor: 22.113

  10 in total
  6 in total

1.  Serum amyloid A protein concentration in bone marrow transplantation for beta thalassaemia.

Authors:  M Uguccioni; R Meliconi; E Lalli; S Nesci; C Delfini; G Lucarelli; G Gasbarrini; A Facchini
Journal:  J Clin Pathol       Date:  1992-04       Impact factor: 3.411

2.  Comparative study of C reactive protein and serum amyloid A protein in experimental inflammation.

Authors:  R E Chambers; C W Hutton; P A Dieppe; J T Whicher
Journal:  Ann Rheum Dis       Date:  1991-10       Impact factor: 19.103

3.  Value of serum C-reactive protein measurement in the management of bone marrow transplant recipients. Part I: Early transplant period.

Authors:  S A Walker; T R Rogers; P G Riches; S White; J R Hobbs
Journal:  J Clin Pathol       Date:  1984-09       Impact factor: 3.411

4.  Antithrombin III in the diagnosis of infection in febrile neutropenic patients.

Authors:  C C Kibbler; H G Prentice; P Noone
Journal:  J Clin Microbiol       Date:  1988-10       Impact factor: 5.948

5.  High prevalence of metabolic syndrome after allogeneic hematopoietic cell transplantation.

Authors:  N S Majhail; M E Flowers; K K Ness; M Jagasia; P A Carpenter; M Arora; S Arai; L Johnston; P J Martin; K S Baker; S J Lee; L J Burns
Journal:  Bone Marrow Transplant       Date:  2008-08-25       Impact factor: 5.483

6.  Clinical laboratory markers of inflammation as determinants of chronic graft-versus-host disease activity and NIH global severity.

Authors:  L Grkovic; K Baird; S M Steinberg; K M Williams; D Pulanic; E W Cowen; S A Mitchell; F T Hakim; K J Martires; D N Avila; T N Taylor; R B Salit; S D Rowley; D Zhang; D H Fowler; M R Bishop; R E Gress; S Z Pavletic
Journal:  Leukemia       Date:  2011-10-18       Impact factor: 11.528

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.